izpis_h1_title_alt

Comparison of ADVIA Centaur ultra-sensitive and high-sensitive assays for troponin I in serum
ID Osredkar, Joško (Avtor), ID Fabjan, Teja (Avtor), ID Kumer, Kristina (Avtor), ID Tršan, Jure (Avtor), ID Poljančič, Laura (Avtor), ID Košir, Miha (Avtor), ID Vovk, Pia (Avtor), ID Snoj, Nada (Avtor), ID Finderle, Petra (Avtor), ID Možina, Hugon (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,57 MB)
MD5: D7D34255E1ED79487A6313BF34F1DEF1
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S2352551722000324 Povezava se odpre v novem oknu

Izvleček
Cardiac troponin I (cTnI) is a standard biomarker for the diagnosis of acute myocardial infarction (AMI). While older, ultra-sensitive cTnI (us-cTnI) assays use the 99th percentile as the reference threshold, newer high-sensitive cTnI (hs-cTnI) assays use the limit of detection or functional sensitivity instead. However, little has been done to systematically compare these two methods. The present study also served as a validation of hs-cTnI in our laboratory. Here, we compared the results obtained from the blood serum obtained from 8810 patients using the us-cTnI and the hs-cTnI assays run in tandem on the ADVIA Centaur XP analyser. We found that in 2279 samples the concentration of cTnI measured with the ultra-sensitive method was below the detection limit, while with the high-sensitive method, only 540 were below the detection limit. We also compared results from these assays with the ultimate diagnosis of a subset of individuals. The analysis of the results below cut-off with the ultra-sensitive method showed that this method would not detect 96 cases related to heart disorder. Overall, the main finding of our research is that hs-cTnI is the preferable option and is able to be deployed effectively in the laboratory setting.

Jezik:Angleški jezik
Ključne besede:acute coronary syndrome, myocardial infarction, troponin I, verification
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2022
Št. strani:6 str.
Številčenje:Vol. 31, art. e00293
PID:20.500.12556/RUL-139678 Povezava se odpre v novem oknu
UDK:616-074:616.127-005.8+616.132.2
ISSN pri članku:2352-5517
DOI:10.1016/j.plabm.2022.e00293 Povezava se odpre v novem oknu
COBISS.SI-ID:115290371 Povezava se odpre v novem oknu
Datum objave v RUL:06.09.2022
Število ogledov:407
Število prenosov:76
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Practical laboratory medicine
Založnik:Elsevier
ISSN:2352-5517
COBISS.SI-ID:526495513 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:verifikacija, troponin I, miokardni infarkt, akutni koronarni sindrom, klinična kemija

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj